Copyright
©2014 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 28, 2014; 20(4): 1067-1073
Published online Jan 28, 2014. doi: 10.3748/wjg.v20.i4.1067
Published online Jan 28, 2014. doi: 10.3748/wjg.v20.i4.1067
Table 3 Dose-limiting toxicities of chemoradiotherapy
| Level | Capecitabine (mg/m2, bid) | n | No. patients with the DLT | DLT (G3/4) | RT dose when DLT occurred (Gy) |
| I | 625 | 6 | 1 | Nausea, vomiting, anorexia | 5.4 |
| II | 700 | 6 | 1 | Nausea, anorexia | 45 |
| III | 800 | 6 | 1 | Neutropenia | 36 |
| 1 | Radiation esophagitis | 43.2 |
- Citation: Wang X, Jin J, Li YX, Ren H, Fang H, Wang SL, Liu YP, Wang WH, Yu ZH, Song YW, Liu XF. Phase I study of postoperative radiotherapy combined with capecitabine for gastric cancer. World J Gastroenterol 2014; 20(4): 1067-1073
- URL: https://www.wjgnet.com/1007-9327/full/v20/i4/1067.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i4.1067